Abstract
Hartwellet al. show that the oestrogen-responsive pituitary hormone prolactin might cause some of the gender bias in hepatocellular carcinoma (HCC) development, and therapeutic activation of prolactin signalling might reduce HCC risk.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have